Tharimmune ( NASDAQ: THAR ) entered an agreement for the purchase and sale of an aggregate of 659,545 shares of its common stock and warrants to purchase up to 329,771 shares of common stock at $3.16 per share of common stock and accompanying warrants in a private placement. The gross proceeds to the company from the offering are expected to be approximately $2.
08 million. The warrants will have an exercise price of $3.09 per share and will be exercisable beginning six months after issuance and expire five and one-half years after issuance.
Source: Press Release More on Tharimmune, Inc. Seeking Alpha’s Quant Rating on Tharimmune, Inc. Historical earnings data for Tharimmune, Inc.
Financial information for Tharimmune, Inc..
